The acquisition of Anthos Therapeutics could be worth up to $3.1 billion and returns to Novartis a blood thinner it licensed to the Blackstone-backed startup six years ago.

When people survive catastrophic events such as wildfires or hurricanes, and then are left to cope with loss, they may ...

The "Spatial Proteomics market - Global industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's offering. The Spatial Proteomics Market ...

According to the child advocacy organization Enough Abuse, 37 states have criminalized AI-generated or AI-modified CSAM, either by amending existing child sexual abuse material laws or enacting new ...

Booking Holdings is a leading online travel company with a $160 billion market cap, showing solid financial position and long ...

The growth of the cell culture media market is driven by rising demand for biopharmaceuticals, vaccines, and cell-based therapies, fueled by advancem ...

Anthos Therapeutics was set up by Blackstone Life Sciences after it licensed abelacimab drug from Novartis in 2019 ...

Mark Hartley examines the knock-on effect that Trump tariffs could have on the UK stock market and considers a stock that ...

Highlights,ARS Pharmaceuticals (SPRY) has received favorable market target projections from research experts.,Significant ...

The Penn Center for Innovation has enabled world-changing advancements, from mRNA vaccines to CAR T cancer treatments.

Schools of fish are mesmerizing examples of collective animal behavior. Thousands of individuals move in near-perfect ...